{"id":11436,"date":"2017-11-09T10:50:27","date_gmt":"2017-11-09T09:50:27","guid":{"rendered":"https:\/\/www.bm-t.de\/v4\/2021\/bmt-investment-inflarx-from-jena-goes-public-on-the-us-stock-exchange-nasdaq\/"},"modified":"2021-01-28T14:00:22","modified_gmt":"2021-01-28T13:00:22","slug":"bmt-investment-inflarx-from-jena-goes-public-on-the-us-stock-exchange-nasdaq","status":"publish","type":"post","link":"https:\/\/www.bm-t.de\/en\/2017-en\/bmt-investment-inflarx-from-jena-goes-public-on-the-us-stock-exchange-nasdaq\/","title":{"rendered":"bm|t investment inflaRx from Jena goes public on the US stock exchange NASDAQ"},"content":{"rendered":"<p>Thuringia-based biotech com\u00adpany <a href=\"http:\/\/www.inflarx.com\">inflaRx<\/a> (NASDAQ: IFRX) suc\u00adcess\u00adfully com\u00adpleted its ini\u00adtial pub\u00adlic offer\u00ading on the US tech\u00adnol\u00adogy exchange Nas\u00addaq yes\u00adter\u00adday, rais\u00ading around $100 million.<\/p>\n<p>The com\u00adpany placed 6,667,000 com\u00admon shares at $15 each yes\u00adter\u00adday, rais\u00ading gross pro\u00adceeds of approx\u00adi\u00admately $100 mil\u00adlion. In addi\u00adtion, the under\u00adwrit\u00aders have the option to pur\u00adchase an addi\u00adtional 1,000,050 shares at the issue price via an over-allot\u00adment option over a 30-day period. JP Mor\u00adgan, BMO Cap\u00adi\u00adtal Mar\u00adkets and Leerink Part\u00adners acted as book-run\u00adning managers.<\/p>\n<p>InflaRx spe\u00adcialises in the devel\u00adop\u00adment of first-in-class block\u00aders for inflam\u00adma\u00adtory and autoim\u00admune dis\u00adeases. The most advanced is the pro\u00adduc\u00adtion cadi\u00addate IFX\u20111 against sweat gland abscess (hidradeni\u00adtis sup\u00adpurtiva). In the prod\u00aduct pipeline are active sub\u00adstances against other chronic and autoim\u00admune diseases.<\/p>\n<p>The bm|t con\u00adgrat\u00adu\u00adlates the team around Dr. Niels Riede\u00admann on this great suc\u00adcess. We are very proud to have accom\u00adpa\u00adnied the com\u00adpany as an investor since day one and thus to have made another Thuringian suc\u00adcess story possible.<br>\nHere you can find more infor\u00adma\u00adtion: <a href=\"http:\/\/www.inflarx.de\/Home\/Investors\/Press-Releases\/11-2017--InflaRx-Announces-Pricing-of-Initial-Public-Offering.html\">www.inflarx.de\/Home\/Investors\/Press-Releases\/11\u20132017<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Thuringia-based biotech com\u00adpany inflaRx (NASDAQ: IFRX) suc\u00adcess\u00adfully com\u00adpleted its ini\u00adtial pub\u00adlic offer\u00ading on the US tech\u00adnol\u00adogy exchange Nas\u00addaq yes\u00adter\u00adday, rais\u00ading around $100 mil\u00adlion. The com\u00adpany placed 6,667,000 com\u00admon shares at $15 each yes\u00adter\u00adday, rais\u00ading gross pro\u00adceeds of approx\u00adi\u00admately $100 mil\u00adlion. In addi\u00adtion, the under\u00adwrit\u00aders have the option to pur\u00adchase an addi\u00adtional 1,000,050 shares at&nbsp;the&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[146],"tags":[],"class_list":["post-11436","post","type-post","status-publish","format-standard","hentry","category-2017-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts\/11436","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/comments?post=11436"}],"version-history":[{"count":0,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/posts\/11436\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/media?parent=11436"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/categories?post=11436"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bm-t.de\/en\/wp-json\/wp\/v2\/tags?post=11436"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}